screened potential participants and helped edit the manuscript. Evidence for constitutive receptor activation in animal models of complete spinal cord injury was 83 provided by the combined finding that neutral antagonists, which only block ligand activation of the 84 5HT2 (e.g., SB242084/methysergide) and α1 (REC15/2739) receptors were ineffective in reducing 85 the CaPIC whereas inverse agonists (e.g., 5HT2: SB206553/cyproheptadine; α1: WB4010/prazosin), 86 which block both ligand and constitutive activation of these receptors, effectively reduced the CaPIC 6 stimulator (NL703, Digitimer, Hertfordshire, UK). The intensity of stimulation was chosen to 160 maximize the duration of the evoked reflex without being too painful for the subject. Higher 161 stimulation intensities were needed in the motor complete SCI participants (75.0 ± 22.0 mA) 162 compared to the incomplete SCI participants (27.6 ±11.8 mA, p < 0.001 Mann-Whitney).
163
Stimulation was repeated 6 times at 5-10s intervals for each trial. Two to three trials were taken 164 before drug administration to establish a stable baseline. Reflex measures were repeated every 30 
191
To measure the amplitude of the various reflex components using Matlab software, each
192
EMG trace was first rectified and the mean EMG was calculated for the SPR, LPR and LLR time 
Estimation of PIC amplitude

222
Data were analyzed off-line using commercial spike discrimination software (Spike2,
223
Cambridge Electronic Design). Single motor unit action potentials were first selected by setting a 224 horizontal threshold, and inspecting each waveform visually to identify a given motor unit based on 225 waveform shape. When possible, the same motor-unit pair (control and test) was followed both 226 before and after drug administration. However, due to electrode movement during the long 227 experiment (typically 3-4 h), one or both of the motor-unit pairs could be lost, and new unit pairs 228 were sampled after drug intake. In the cyproheptadine experiments, 11 of the 15 motor unit pairs 229 recorded in the iSCI participants were the same both pre and post-drug whereas in the 230 chlorpromazine experiments, 5 of the 7 motor unit pairs recorded in the non-injured control 231 participants were the same both pre and post-drug.
232
The amplitude of PIC activation was estimated utilizing the paired motor unit analysis 
257
All participants, including the iSCI, were able to produce triangular firing rate profiles of the control 258 motor unit that lasted for at least 10 to 15s. These profiles were produced to best emulate the firing In 6 of the 8 iSCI participants (# in Table 1 ), we were able examine the effect of cyproheptadine on 322 the estimated amplitude of the motoneuron PIC using paired motor unit analysis (see "Estimation of 323 PIC amplitude" in Methods). Briefly, the firing rate of a lower-threshold, control motor unit recorded 324 from the tibialis anterior (bottom graphs) was used as a measure of synaptic drive to a higher-325 threshold, test motor unit (top graphs) during a triangular voluntary dorsiflexion ( Fig. 2A) . The 326 difference in the smoothed firing rate of the control motor unit when the test motor unit was de-327 recruited, compared to when it was recruited (ΔF), was used as a measure of the reduction in synaptic 328 input needed to counteract the depolarization from the PIC and provides an indirect estimate of PIC 329 amplitude. As shown for the single subject in Figure 2A , the higher-threshold test motor unit was de-330 recruited at a higher firing rate of the control motor unit at 60 minutes after cyproheptadine (right 331 panels) compared to before (left panels). This produced a decrease in the ΔF measurement (arrows in Although the test unit was de-recruited earlier, the firing rate profile of the control motor unit 337 remained similar after cyproheptadine with a mean firing rate throughout the contraction of (Fig. 3B) . The average LLR increased by 152± 67% in the 4 iSCI 368 participants tested with citalopram ( Fig. 3D; F The dose of cyproheptadine was increased to 12 mg because an 8 mg dose was minimally effective in 384 two pilot participants with motor complete SCI (data not shown). The data from 9 cSCI participants 385 (10M-18M, Table 1 ) showed similar effects with a 48±12% reduction in the LLR averaged over 30 to 386 120 minutes after drug intake ( Fig. 4C; F=13 .93, p<0.001) and a smaller 22±10% reduction in the 387 LPR over the same time period (Fig. 4B; F=4 .75, p=0.005). Post-hoc analysis revealed that many 388 time points were significantly smaller post-drug (see Figs. 4C and B; all p < 0.05). A distinct, early-389 latency SPR was recorded in only 2 of the 9 cSCI participants and thus, was not analyzed further. When we examined the effects of chlorpromazine on the ΔF in non-injured (NI) control 411 participants having full sources of serotonin/noradrenaline, chlorpromazine was effective in reducing 412 the ΔF at 90 and 120 minutes post-drug intake (F = 6.72, p = 0.011; 90 and 120 min p < 0.05).
413
Contractions were similar before and after drug intake as reflected in similar mean firing rates of the 
419
In contrast to the non-injured controls, chlorpromazine had no effect on either the LPR (Fig.   420 5C) or LLR (Fig. 5D ) in the cSCI participants with likely little to no residual serotonin or little to no CaPIC was reduced by 5% on average, the LPR that is partly mediated by the CaPIC was 473 reduced by 30%, and the LLR which is mainly mediated by the CaPIC was reduced by 60%. This 474 suggests that cyproheptadine selectively reduced the CaPIC via its action on the 5HT2/α1 receptors.
475
In agreement with the PIC-mediated LLR, the more direct estimation of PIC amplitude via the 476 ΔF measures was also reduced by cyproheptadine. Thus, the ΔF measurement is sensitive to drug 477 effects as was also shown for the chlorpromazine data in this paper and previously for amphetamine There is strong supportive evidence that chlorpromazine, at the doses used in this study, acted 
Constitutive 5HT2/α1 receptor activity in iSCI 531
Although we cannot prove the existence of constitutive 5HT2/α1 receptor activity in the motor 532 incomplete spinal cord participants using pharmacology, this does not mean that constitutive receptor 533 activity is absent in these participants or in the non-injured control participants for that matter. For be desirable in patients with incomplete SCI because it would also weaken activation of the 583 motoneuron from spared descending inputs, this is not a concern in motor complete SCI.
584
Cyproheptadine has been shown to be as effective in reducing excessive muscle activation 585 compared to clonidine and baclofen in spastic, spinal cord injured patients (Nance 1994) and at a 586 dose of 12mg/day, it was well tolerated during a 2-month trial (Wainberg et al. 1990 ). Associated Table 1 ). * p < 0.05. Table 1 ). * p < 0.05. 
